BEIJING, January 12 (TMTPOST) Six companies that are to be listed on the Beijing Stock Exchange have adjusted their offering plans and lowered their offering base prices to net assets per share.
Companies that have lowered their issuance price include Ovodan, Baijia Technology, Lierda, and Jiangxi Xinganjiang Pharmaceutical. Among them, Beijing Baolijie Technology Development adjusted the base price from 16.00 yuan ($2.37) per share to 13.00 yuan ($1.93)per share. Thereafter, the base price of the issue was adjusted from 10.01 yuan ($1.49)per share to 5.79 yuan ($0.85) per share. The cumulative range of the base price of the issue was reduced by 63.8% three times, and the final PB was doubled in 2021. Lierda adjusted the issue base price from $7 per share to $1.72 per share, down 75%.
In addition, the first issue of Jiangxi Xinganjiang Pharmaceutical will be suspended for review, and the floor price of the issue will be adjusted from not less than 13.10 yuan ($1.94) per share to not less than 12.50 yuan ($1.85) per share. The second issue will be passed. The adjustment of the issue plan is mainly related to the number of issued shares, and the adjusted issue price per share is not less than 4.53 yuan ($0.67) per share.
The adjustment of the number of shares issued, the issue floor price, and the total amount of funds raised, and the purpose, is mainly based on the situation of the securities market and the need to maintain the stability of stock prices.
In this regard, people close to the supervision said that the adjustment of the issuing floor price of new shares to the net asset level per share is mainly to increase the space for inquiry of new shares to improve the valuation and pricing mechanism of new shares in the Beijing Stock Exchange market.
